Hongbin Chen, MD, PhD

Assistant Professor
Department of Medicine
Roswell Park Cancer Institute
Clinical Assistant Professor of Medicine
Department of Medicine
School of Medicine and Biomedical Sciences, State University of New York at Buffalo

Profile

Areas of Expertise: 
Lung Cancer
Mesothelioma
Thymic malignancies

Research

Research Interests: 
Targeted personalized therapy in lung cancer
Geriatric Oncology

Background Information

Education and Training: 
MD - Shanghai Medical University, Shanghai, China
PhD - University of South Florida, Tampa, FL
Residency: 
State University of New York at Buffalo, Buffalo, NY
Board Certification: 
Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Fellowships: 
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Professional Memberships: 
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

Publications

Publications: 
  • Farooq A, Dy GK, Demmy TL, Bogner P, Nowadly C, Tan W, Chen H, Yendamuri SS, Nwogu CE, Bushunow PW, Adjei AA, Ramnath N. Phase II study of perioperative chemotherapy with cisplatin (C) and pemetrexed (P) in non-small cell lung cancer (NSCLC) : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e17535
  • Dickerson SS, Sabbah EA, Ziegler P, Chen H, Steinbrenner LM, Dean G. The experience of a diagnosis of advanced lung cancer: sleep is not a priority when living my life. Oncology nursing forum 2012; 39(5):492-499